Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The supraorbital nerve is a sensory branch of the frontal nerve, itself a division of the ophthalmic branch (V1) of the trigeminal nerve (cranial nerve V)[1][2][3][4][5]. It exits the orbit via the supraorbital foramen or notch, divides into medial and lateral branches, and supplies sensory innervation to the forehead, upper eyelid, conjunctiva, and frontal sinus mucosa[1][2][3][4][5]. The nerve is clinically significant in procedures such as nerve block for headache management, browplasty, and reconstructive surgery, where its anatomical variability poses risk for inadvertent injury[3][5]. While not a biochemical target, the supraorbital nerve is a focal point in clinical neurology/anesthesia for pain management[3][5].
Nerve block—reversible inhibition of nerve signal transmission via sodium channel blockade (local anesthetics) - Neurostimulation (modulating afferent sensory signals for migraine therapy)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Supraorbital nerve.